BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Varma DM, Redding EA, Bachelder EM, Ainslie KM. Nano- and Microformulations to Advance Therapies for Visceral Leishmaniasis. ACS Biomater Sci Eng 2021;7:1725-41. [DOI: 10.1021/acsbiomaterials.0c01132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tuon FF, Dantas LR, de Souza RM, Ribeiro VST, Amato VS. Liposomal drug delivery systems for the treatment of leishmaniasis. Parasitol Res. [DOI: 10.1007/s00436-022-07659-5] [Reference Citation Analysis]
2 Das SS, Dubey AK, Verma PRP, Singh SK, Singh SK. Therapeutic Potential of Quercetin-Loaded Nanoemulsion against Experimental Visceral Leishmaniasis: In Vitro/Ex Vivo Studies and Mechanistic Insights. Mol Pharm 2022. [PMID: 35980291 DOI: 10.1021/acs.molpharmaceut.2c00492] [Reference Citation Analysis]
3 Wijnant G, Dumetz F, Dirkx L, Bulté D, Cuypers B, Van Bocxlaer K, Hendrickx S. Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis. Front Trop Dis 2022;3:837460. [DOI: 10.3389/fitd.2022.837460] [Reference Citation Analysis]
4 Joshi G, Quadir SS, Yadav KS. Road map to the treatment of neglected tropical diseases: Nanocarriers interventions. J Control Release 2021;339:51-74. [PMID: 34555491 DOI: 10.1016/j.jconrel.2021.09.020] [Reference Citation Analysis]
5 Peters EB, Banerjee R. Special Issue: Nanomedicine Advances in Infectious Disease. ACS Biomater Sci Eng 2021;7:1722-4. [PMID: 33966378 DOI: 10.1021/acsbiomaterials.1c00521] [Reference Citation Analysis]
6 Tiwari R, Banerjee S, Tyde D, Saha KD, Ethirajan A, Mukherjee N, Chattopadhy S, Pramanik SK, Das A. Redox-Responsive Nanocapsules for the Spatiotemporal Release of Miltefosine in Lysosome: Protection against Leishmania. Bioconjug Chem 2021;32:245-53. [PMID: 33438999 DOI: 10.1021/acs.bioconjchem.0c00667] [Cited by in F6Publishing: 2] [Reference Citation Analysis]